17-12-03
Thirteen research projects, to be carried out at six leading institutions across the country, have been selected to spearhead the strategic efforts of Australia’s National Stem Cell Centre (NSCC).
The projects fall under the NSCC’s four core research platforms – embryonic stem cells, adult stem cells, tissue repair and immune modulation – as well as two therapeutic focus programs focussing on products for the treatment of blood and heart diseases. These will include therapeutics for the treatment of diseases such as leukaemia and chronic heart failure.
In another development, Dr Hugh Niall, a founding Director of the NSCC and former CEO of listed biotech company Biota Holdings Ltd, has been confirmed in the position of Chief Executive Officer of the NSCC.
Download the full media release below.
Downloads
National Stem Cell Centre Funds Pioneering Research Projects (58122)
Other Reports